Tag: carcinoid

Go Zebra-Striped for NET Cancer Day

Go Zebra-Striped for NET Cancer Day

October 23, 2016

We’re incredibly excited to share our app worldwide to raise awareness of carcinoid and neuroendocrine cancers on and around NET Cancer Day, November 10, and throughout the year. Follow the directions here, https://www.carcinoid.org/go-zebra-striped/

READ MORE

Neuroendocrine Tumors to Be Focus of Presentations and Posters at ASCO Gastrointestinal Cancers Symposium

January 14, 2016

Presentations on recent advances in the treatment of neuroendocrine tumors (NETs) and new findings from the NETTER-1 clinical study on PRRT with Lutathera along with posters on a wide variety of subjects about NETs will be part of the program during the…

READ MORE
Learn More about NET Cancer

Intelligent Patients — Just What the Doctor Didn’t Order by Ronny Allan

January 28, 2015

The Carcinoid Cancer Foundation is pleased to announce that we are going to feature guest contributors to our blog during 2015. Intelligent Patients – Just What the Doctor Didn’t Order by Ronny Allan (pictured), a carcinoid cancer patient from the…

READ MORE

North Carolina Golf Tournament Raises Awareness of Carcinoid Cancer and Funds for the Carcinoid Cancer Foundation

June 19, 2014

Larry Sanders, Plant Engineer at Arclin USA in Moncure, North Carolina, and his colleagues held the Arclin’s Men and Women’s Golf Tournament on May 24, 2014 to express appreciation for those who work at the plant and for Arclin’s clients and to raise…

READ MORE
Warner Advocacy Award 2014: Call for Nominations

Call for Nominations: 2014 Warner Advocacy Award

June 6, 2014

Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? The NET Alliance™ and Novartis Oncology have announced the 2014 Warner Advocacy Award, named in honor of the late Monica Warner, a driving force behind…

READ MORE
Sandostatin, Celebrating 25 Years

Novartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program

March 31, 2014

A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.

With the Sandostatin® LAR Depot Co-Pay Assistance Program

READ MORE
Stephen J. Marx, MD

Multiple Endocrine Neoplasia (MEN) Patient and Family Seminar in Chicago

February 14, 2014

Multiple Endocrine Neoplasia 1 and 2 patients and their families are invited to a free, half-day education seminar on Saturday, March 22, 2014, presented by the Lurie Cancer Center of Northwestern University in Chicago, Illinois and American Multiple

READ MORE

Mobile Survey for Carcinoid Syndrome Community

January 16, 2014

Carcinoid syndrome patients, caregivers, and advocates in the carcinoid syndrome community are invited to participate in an exclusive mobile survey being conducted by WEGO Health via Truvio.

WEGO Health is an organization committed to empowering…

READ MORE
Molly Clarke is a blogger who writes about Social Security Disability issues

Carcinoid and Neuroendocrine Tumors and Social Security Disability Benefits

December 15, 2013

Carcinoid tumors are usually slow growing tumors that arise from the neuroendocrine system, which produces hormones. Many carcinoids begin in the digestive track and can lead to carcinoid syndrome, which refers to an array of symptoms that occur as …

READ MORE
Phase III Clinical Trial of Teo

Discover Something New in Carcinoid Syndrome

November 11, 2013

For patients who suffer from carcinoid syndrome – with symptoms such as diarrhea, frequent bowel movements, abdominal pain, and flushing – that is not adequately controlled by their current somatostatin analog therapy, there is an opportunity…

READ MORE